223 related articles for article (PubMed ID: 17394902)
1. Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.
Wathen M
Am Heart J; 2007 Apr; 153(4 Suppl):44-52. PubMed ID: 17394902
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
3. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial.
Sweeney MO; Wathen MS; Volosin K; Abdalla I; DeGroot PJ; Otterness MF; Stark AJ
Circulation; 2005 Jun; 111(22):2898-905. PubMed ID: 15927965
[TBL] [Abstract][Full Text] [Related]
4. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
Grimm W; Plachta E; Maisch B
Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
[TBL] [Abstract][Full Text] [Related]
5. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
6. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
7. Improvement of quality of life by means of antitachy pacing: from PainFREE to the ADVANCE-D Trial.
Lunati M; Defaye P; Mermi J; Garcia-Alberola A; Merino JL; Arenal A; Cappato R; Navarro X; Passardi M; Santini M
Pacing Clin Electrophysiol; 2006 Dec; 29 Suppl 2():S35-9. PubMed ID: 17169131
[TBL] [Abstract][Full Text] [Related]
8. Optimizing ICD programming for shock reduction.
Schwab JO
Fundam Clin Pharmacol; 2010 Oct; 24(5):653-9. PubMed ID: 20854304
[TBL] [Abstract][Full Text] [Related]
9. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
[TBL] [Abstract][Full Text] [Related]
10. Discriminatory therapy for very fast ventricular tachycardia in patients with implantable cardioverter defibrillators.
Sivagangabalan G; Eshoo S; Eipper VE; Thiagalingam A; Kovoor P
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1095-9. PubMed ID: 18834458
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmia rate distribution and tachyarrhythmia therapy in an ICD population: results from the INTRINSIC RV trial.
Sullivan RM; Russo AM; Berg KC; Stolen KQ; Seth M; Perschbacher D; Day JD; Olshansky B
Heart Rhythm; 2012 Mar; 9(3):351-8. PubMed ID: 22016074
[TBL] [Abstract][Full Text] [Related]
12. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.
Schwab JO; Gasparini M; Lunati M; Proclemer A; Kaup B; Santi E; Ligorio G; Klersy C; DE Sousa J; Okreglicki A; Arenal A; Wijffels M; Lemke B
J Cardiovasc Electrophysiol; 2009 Jun; 20(6):663-6. PubMed ID: 19175450
[TBL] [Abstract][Full Text] [Related]
13. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic exhaustion in patients with an implantable cardioverter-defibrillator. Are there predisposing factors?].
Oliveira M; da Silva N; Antunes E; Sousa L; Bico P; Conceição JM; Roquette J; Antunes AM
Rev Port Cardiol; 1998 Dec; 17(12):1013-20. PubMed ID: 9973863
[TBL] [Abstract][Full Text] [Related]
15. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
[TBL] [Abstract][Full Text] [Related]
16. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
[TBL] [Abstract][Full Text] [Related]
17. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease.
Wathen MS; Sweeney MO; DeGroot PJ; Stark AJ; Koehler JL; Chisner MB; Machado C; Adkisson WO;
Circulation; 2001 Aug; 104(7):796-801. PubMed ID: 11502705
[TBL] [Abstract][Full Text] [Related]
18. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
[TBL] [Abstract][Full Text] [Related]
19. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
[TBL] [Abstract][Full Text] [Related]
20. [Antitachycardia pacing in patients with left ventricular dysfunction and hemodynamically unstable arrhythmias].
Oliveira M; Antunes E; da Silva N; Martins S; Conceição JM; Roquette J; Antunes AM
Rev Port Cardiol; 1999 Feb; 18(2):161-6. PubMed ID: 10221046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
